Cynthia Laughren
No ORCID on file
· 2 papers in corpus
other
2014
INTRODUCTION: BRCA mutations increase the risk for development of high-grade pelvic serous carcinomas. Tissue biomarkers distinguishing women at high-risk (HR) for ovarian cancer from those at low-risk (LR) may provide insights into tumor i…
nonrandomized-trial
2014
Flutamide and biomarkers in women at high risk for ovarian cancer: preclinical and clinical evidence
We hypothesized that (i) preclinical biologic evidence exists for the role of androgens in ovarian cancer development and (ii) flutamide treatment of women at high risk for ovarian cancer may identify meaningful tissue biomarkers of androge…